Adjuvant chemotherapy with S-1 for patients with head and neck cancer after radical therapy: A phase I/II feasibility study. Background: E10A is an adenovirus containing human endostatin gene (Ad-rhE) ...
Between April 2005 and January 2006, 15 patients (nine men and six women) were enrolled onto this clinical trial (Table 1). Median age was 45 years (range: 33–59 years). Nine patients had head and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback